A、Entity integrity
B、Referential integrity
C、Check constraint
D、User defined constraint
第1题
第2题
【C1】
A.Adequate
B.Inadequate
C.Sufficient
D.Abnormal
第3题
A.In a military base in Iraq.
B.In a visit to Washington.
C.In a military base in Texas.
D.In a visit to Baghdad.
第4题
A.When using a mksysb to clone a system that has had device driver updates applied, the target system does not need to be updated with device driver Updates to match the source systems level, as the mksysb will have the needed drivers.
B.CHRP architecture systems cloned form non-CHRP architecture systems with Updates applied may fail to boot due to incompatibilities between the updated kernel in the mksysb image and the base level devices.chrp.base.rte fileset installed during the cloning process.
C.If the source and target system kernels are different (for example, rs6k and rspc), one MUST boot from CD-ROM installation media, at the same operating system level as the mksysb being restored.
D.The RECOVER_DEVCIES option allows the choice to recover the customized ODM attributes from the mksysb(for example, network addressing, static routes, tty settings, and multi-port adapter cards). The target devices must be in The same location as the source machine, or the install will fail and the device wil not be defined.
第5题
China is fast applying the latest life-science techniques learned from the West m aggressively pursue genome research. It's establishing its own centers of technical excellence to build a scientific base to compete directly with the United States and Europe. With a plentiful supply of smart young scientists at home and lots of interest abroad biotechnology is on the brink of a boom in China and in the view of foreign scientists, Beijing is playing a clever hand, maximizing the opportunities open to them.
For the moment, the cooperation exists mostly with Europe and the U. S. But Asia's other biotech leaders, Japan, Singapore and Korea, also are recognizing China's potential as an attractive low-cost base to conduct research. These partnerships--and China's advancement in the field of biotechnology--could help benefit the rest of Asia: China's rapid progress in improving crop yields will address food-security concerns in the region. In addition, China is more likely to focus on developing cheap technology that its predominantly poor population--and those of other Asian countries--can afford.
There remain, however, serious barriers to the development of a strong biotech industry. Among them are a poor domestic legal framework, weak enforcement of intellectual-property rights and loose adherence to international standards. China is a signatory of the International Bio Safety Protocol, which should mean adherence to global standards governing the conduct of field trims. But some observers are skeptical. "The regulations look good, but I haven't met one scientist who believes they are being fully adhered to," says a European science analyst.
If shortcuts are taken, then some of the recent scientific achievements trumpeted in the official press may never make it to market. But no matter how strict lab tests are, other problems lie in wait. For example, there is a number of tasks it would take years to fulfill in the patents office, says one lawyer, leaving innovators with little protection if they take a product to market in China.
The mouse on display is most significant in that ______.
A.it has an ear in the shape of a human ear
B.it is unusually small and ugly as a star
C.it is the focus of. the media at the exhibition
D.it indicates China's progress in biotechnology
第6题
A.basis
B.bases
C.base
D.basises
为了保护您的账号安全,请在“上学吧”公众号进行验证,点击“官网服务”-“账号验证”后输入验证码“”完成验证,验证成功后方可继续查看答案!